NurExone Biologic Inc. is a publicly-traded biopharmaceutical company, listed on the Toronto Stock Exchange (TSXV: NRX), the OTCQB Venture Market (OTCQB:NRXBF) and Frankfurt Stock Exchange (TSXV: NRX). Developing and commercializing the ExoTherapy platform for production of exosome-loaded nanodrugs.

Content Locked
Login or Register a FREE account to continue browsing our content
2020
Haifa, Israel
Israel

-
Post-IPO Equity| Funding Round | Announced Date | Disclosed Investors | Round Amount (USD) |
|---|
Content Locked
Login or Register a FREE account to continue browsing our content
Register for our free weekly newsletter
Stay up to date with the latest news, special reports, videos, infobytes, and features on the region's most notable entrepreneurial ecosystems